BK virus nephropathy in renal transplant recipients
- PMID: 26780694
- DOI: 10.1111/nep.12728
BK virus nephropathy in renal transplant recipients
Abstract
BK virus nephropathy (BKVN) occurs in up to 10% of renal transplant recipients and can result in graft loss. The reactivation of BK virus in renal transplant recipients is largely asymptomatic, and routine surveillance especially in the first 12-24 months after transplant is necessary for early recognition and intervention. Reduced immunosuppression and anti-viral treatment in the early stages may be effective in stopping BK virus replication. Urinary decoy cells, although highly specific, lack sensitivity to diagnose BKVN. Transplant biopsy remains the gold standard to diagnose BKVN, good surrogate markers for surveillance using quantitative urinary decoy cells, urinary SV40 T immunochemical staining or polyoma virus-Haufen bodies are offered by recent studies. Advanced BKVN results in severe tubulo-interstitial damage and graft failure. Retransplantation after BKVN is associated with good outcomes. Newer treatment modalities are emerging.
Keywords: polyoma BK virus; transplant dysfunction; two-hit hypothesis.
© 2016 Asian Pacific Society of Nephrology.
Similar articles
-
Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.Clin Transpl. 2014:109-16. Clin Transpl. 2014. PMID: 26281134
-
BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions.Exp Clin Transplant. 2016 Aug;14(4):377-84. doi: 10.6002/ect.2016.0030. Epub 2016 Jun 3. Exp Clin Transplant. 2016. PMID: 27267780 Review.
-
Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.Exp Clin Transplant. 2019 Jan;17(Suppl 1):83-91. doi: 10.6002/ect.MESOT2018.O17. Exp Clin Transplant. 2019. PMID: 30777529
-
Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy.Nephrology (Carlton). 2015 Jul;20 Suppl 2:45-50. doi: 10.1111/nep.12462. Nephrology (Carlton). 2015. PMID: 26031586
-
Low prevalence of BK virus nephropathy on nonprotocol renal biopsies in Iranian kidney transplant recipients: one center's experience and review of the literature.Exp Clin Transplant. 2010 Dec;8(4):297-302. Exp Clin Transplant. 2010. PMID: 21143095 Review.
Cited by
-
Urinary Tract Virome as an Urgent Target for Metagenomics.Life (Basel). 2021 Nov 19;11(11):1264. doi: 10.3390/life11111264. Life (Basel). 2021. PMID: 34833140 Free PMC article. Review.
-
Clearance of BK Virus Nephropathy by Combination Antiviral Therapy With Intravenous Immunoglobulin.Transplant Direct. 2017 Mar 10;3(4):e142. doi: 10.1097/TXD.0000000000000641. eCollection 2017 Apr. Transplant Direct. 2017. PMID: 28405598 Free PMC article.
-
Influence of Calcineurin Inhibitor and Sex on Mycophenolic Acid Pharmacokinetics and Adverse Effects Post-Renal Transplant.J Clin Pharmacol. 2019 Oct;59(10):1351-1365. doi: 10.1002/jcph.1428. Epub 2019 May 6. J Clin Pharmacol. 2019. PMID: 31062373 Free PMC article.
-
Risk factors for BK virus infection in living-donor renal transplant recipients: a single-center study from China.Ren Fail. 2018 Nov;40(1):442-446. doi: 10.1080/0886022X.2018.1489843. Ren Fail. 2018. PMID: 30052479 Free PMC article.
-
Prediction of Early BK Virus Infection in Kidney Transplant Recipients by the Number of Cells With Intranuclear Inclusion Bodies (Decoy Cells).Transplant Direct. 2018 Feb 2;4(2):e340. doi: 10.1097/TXD.0000000000000759. eCollection 2018 Feb. Transplant Direct. 2018. PMID: 29464201 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical